MediXall Group, Inc. (MDXL) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerMediXall Group, Inc. (MDXL) trades at $0.0035. MediXall Group, Inc. operates a healthcare marketplace platform aimed at enhancing consumer engagement in healthcare decisions. Sector: Healthcare.
Price as of Sep 10, 2026 · Last analyzed: Jun 14, 2026Analyst Coverage for MDXL: MDXL does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MDXL against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
Dated analysis: the newest financial statements on file are 24 months old (Sep 1, 2024), so the figures and score below describe that period, not today.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
MDXL: the 2 scored disciplines are evenly split. Dominant signal: Seth Klarman bearish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
MediXall Group, Inc. (MDXL) Healthcare & Pipeline Overview
MediXall Group, Inc. is a healthcare marketplace innovator, offering the Health Karma platform to facilitate consumer engagement in healthcare decisions, thereby enhancing relationships with trusted healthcare providers in the U.S.
What Is the Investment Thesis for MDXL?
MediXall Group, Inc. is poised for growth as the demand for healthcare information services increases. The company’s Health Karma platform represents a significant value driver, with the potential to capture a larger share of the healthcare marketplace. The ongoing digital transformation in healthcare, coupled with rising consumer expectations for transparency and accessibility, presents a favorable environment for MediXall. Additionally, the company’s focus on partnerships with employer groups and third-party administrators could lead to increased user adoption and revenue streams. However, the company faces challenges, including a high profit margin deficit of -1474.8%, which underscores the need for operational improvements and strategic investments to enhance profitability over the next few years.
Based on FMP financials and quantitative analysis
MDXL Key Highlights
Market Cap: $0.00B, indicating a nascent stage in market presence.
- Profit Margin: -1474.8%, highlighting significant operational challenges.
- Gross Margin: 23.6%, reflecting the cost structure of service delivery.
- Beta: 274.99, indicating high volatility in stock performance.
- Dividend Yield: None, as the company does not currently distribute dividends.
Who Are MDXL's Competitors?
MDXL is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| AMWL American Well Corporation | $12.87 | +4.59% | $219M | — |
| TDOC Teladoc Health, Inc. | $6.15 | +0.82% | $1.12B | — |
| CLOV Clover Health Investments, Corp. | $4.71 | +8.53% | $2.44B | 375-pillar |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | $0.49 | -1.32% | $9.00M | — |
| BBLN Babylon Holdings Limited | $0.55 | -13.99% | $14.1M | — |
| SCNX Scienture Holdings, Inc. | $0.36 | -2.62% | $14.5M | — |
| BEAT HeartBeam, Inc. | $0.42 | -0.93% | $23.1M | — |
| EUDA EUDA Health Holdings Limited | $13.12 | +0.15% | $24.5M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MDXL's Key Strengths?
Innovative healthcare marketplace platform.
- Focus on consumer empowerment and decision-making.
- Established relationships with employer groups and administrators.
What Are MDXL's Weaknesses?
High negative profit margin indicating operational inefficiencies.
- Limited employee base may restrict growth potential.
- Dependence on partnerships for user acquisition.
What Could Drive MDXL Stock Higher?
Potential integration of telehealth services into the Health Karma platform.
- Expansion of partnerships with employer groups to enhance user acquisition.
- Development of new features to improve user engagement and experience.
What Are the Key Risks for MDXL?
Regulatory changes impacting the healthcare marketplace.
- High operational costs leading to negative profit margins.
- Competition from established healthcare information service providers.
What Are the Growth Opportunities for MDXL?
- Growth opportunity 1: The increasing adoption of telehealth services is a significant growth driver for MediXall. The telehealth market is expected to reach $459.8 billion by 2030, growing at a CAGR of 23.4%. MediXall can leverage this trend by integrating telehealth services into its platform, enhancing user engagement and expanding its service offerings.
- Growth opportunity 2: Expanding partnerships with employer groups can drive user acquisition for MediXall. As employers increasingly seek to provide comprehensive health benefits, MediXall's platform can serve as a valuable resource for employers looking to enhance employee wellness. This market is projected to grow as companies prioritize health benefits, potentially increasing MediXall's user base significantly.
- Growth opportunity 3: The rise of consumer-driven healthcare is reshaping the industry, with patients seeking more transparency and control over their healthcare decisions. MediXall's platform aligns with this trend, providing tools for users to compare services and prices. As this market continues to evolve, MediXall can capture a larger share by enhancing its platform's capabilities.
- Growth opportunity 4: The integration of AI and machine learning into healthcare services presents an opportunity for MediXall to enhance its platform. By utilizing these technologies, the company can offer personalized healthcare recommendations and improve user experience. The AI healthcare market is expected to reach $188 billion by 2030, providing a significant opportunity for growth.
- Growth opportunity 5: Geographic expansion into underserved markets can provide MediXall with new revenue streams. Many regions in the U.S. still lack comprehensive healthcare marketplace solutions. By targeting these areas, MediXall can establish a foothold and cater to a growing population seeking accessible healthcare services.
What Threats Does MDXL Face?
- Intense competition from established healthcare information service providers.
- Regulatory changes impacting healthcare delivery.
- Economic downturns affecting consumer spending on healthcare.
What Are MDXL's Competitive Advantages?
- Unique marketplace model that combines various healthcare services in one platform.
- Strong focus on consumer empowerment and transparency in healthcare decisions.
- Partnerships with employer groups and third-party administrators enhance market reach.
- Innovative technology integration allows for personalized user experiences.
- Small team enables agile decision-making and rapid adaptation to market changes.
What Does MDXL Do?
Founded in 1998 and headquartered in Fort Lauderdale, Florida, MediXall Group, Inc. is a pioneering company in the healthcare information services sector. The company was established to address the growing need for a more transparent and accessible healthcare marketplace. MediXall operates the Health Karma platform, which serves as a comprehensive marketplace for medical and wellness services, enabling consumers to learn about, decide on, and pay for healthcare services in a manner that complements their relationships with healthcare providers. The platform caters to individuals, employer groups, and third-party administrators, positioning itself as a versatile solution in the healthcare ecosystem. With a small team of seven employees, MediXall emphasizes innovation and consumer empowerment in healthcare, striving to streamline the decision-making process for users. As healthcare continues to evolve with digital solutions, MediXall aims to capitalize on this trend by enhancing user experience and expanding its service offerings.
What Products and Services Does MDXL Offer?
- Develops a healthcare marketplace platform to facilitate consumer engagement.
- Offers the Health Karma platform for medical and wellness services.
- Targets individuals, employer groups, and third-party administrators.
- Aims to improve transparency and accessibility in healthcare decisions.
- Provides tools for consumers to learn about, decide on, and pay for healthcare services.
- Focuses on enhancing relationships between consumers and healthcare providers.
How Does MDXL Make Money?
- Generates revenue through service fees associated with transactions on the Health Karma platform.
- Partners with employer groups to provide health benefits and wellness services.
- Offers subscription-based services for third-party administrators.
- Utilizes data analytics to improve service offerings and user experience.
- Focuses on enhancing user engagement to drive repeat usage of the platform.
What Industry Does MDXL Operate In?
The healthcare information services industry is experiencing robust growth, driven by increasing demand for digital healthcare solutions. As consumers seek more control over their healthcare decisions, platforms like MediXall's Health Karma are becoming essential. The market is projected to expand significantly, with a focus on enhancing patient engagement and improving healthcare outcomes. Competitively, MediXall faces challenges from established players but differentiates itself through its unique marketplace approach, targeting both individual consumers and employer groups.
Who Are MDXL's Key Customers?
- Individual consumers seeking medical and wellness services.
- Employer groups looking to provide health benefits to employees.
- Third-party administrators managing health plans.
- Healthcare providers seeking to enhance patient engagement.
- Insurance companies interested in streamlined service offerings.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 368 days ago
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 60 |
| 2026-08-26 | 60 |
| 2026-08-29 | 60 |
| 2026-09-01 | 60 |
| 2026-09-04 | 60 |
| 2026-09-07 | 60 |
| 2026-09-10 | 60 |
What changed?
The score has stayed at 60.
Over the same 18 days the stock moved +0.0%.
MediXall Group, Inc. Financial Trajectory
MediXall Group, Inc. (MDXL) reported $39K in revenue for Q3 FY2024, a decline of 26.5% compared to the prior quarter. The company recorded net income of $264K, with diluted EPS of $0.00. Revenue has contracted over three consecutive quarters, which investors in this unknown Healthcare stock should monitor closely.
Company Profile
MediXall Group, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Leesburg, US. The company is led by CEO Travis Jackson. MDXL has traded publicly since 2003.
Key Financial Metrics
Return on equity for MediXall Group, Inc. stands at 89.5%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
MediXall Group, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile.
MDXL Financials
Bull Case vs Bear Case
Bull Case
- Innovative healthcare marketplace platform.
- Focus on consumer empowerment and decision-making.
- Established relationships with employer groups and administrators.
- Upcoming: Potential integration of telehealth services into the Health Karma platform.
Bear Case
- High negative profit margin indicating operational inefficiencies.
- Limited employee base may restrict growth potential.
- Dependence on partnerships for user acquisition.
- Potential: Regulatory changes impacting the healthcare marketplace.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 FY2024 | $38,858 | $263,813 | $0.0016 |
| Q2 FY2024 | $52,839 | -$485,862 | -$0.0035 |
| Q1 FY2024 | $118,142 | -$486,600 | -$0.0036 |
Q3 FY2024 · filed 8 Sep 2025 · SEC EDGAR →
Based on FMP financials and quantitative analysis
MDXL Latest News
No recent news available for MDXL.
MDXL Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for MDXL.
Price Targets
Wall Street price target analysis for MDXL.
MDXL MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for MDXL; grades run from A+ (80-100) to F (below 30).
Leadership: Travis H. Jackson
CEO
Travis H. Jackson has extensive experience in the healthcare sector, having held various leadership roles since the inception of MediXall Group, Inc. He has a strong background in healthcare technology and business development, which has been instrumental in shaping the company’s strategic direction. Jackson holds a degree in Business Administration and has been pivotal in driving MediXall's innovative approach to healthcare solutions.
Track Record: Under Jackson's leadership, MediXall has launched the Health Karma platform, positioning the company as a key player in the healthcare marketplace. His strategic vision has focused on enhancing consumer engagement and expanding the company's service offerings.
MDXL OTC Market Information
The OTC Other tier represents companies that trade on the over-the-counter market but do not meet the stringent requirements of major exchanges like NYSE or NASDAQ. This tier typically includes smaller companies with less liquidity and visibility, which may pose higher risks for investors.
- OTC Tier: OTC Other
- Higher volatility and price fluctuations compared to stocks on major exchanges.
- Limited financial disclosure and transparency, increasing investment risk.
- Potential for lower investor interest and trading volume.
- Verify the company's financial statements and disclosures.
- Assess the management team's experience and track record.
- Investigate the competitive landscape and market positioning.
- Review the company's growth strategy and potential catalysts.
- Consider the liquidity of the stock and trading volume.
- Incorporation and operational history since 1998.
- Established partnerships with employer groups and administrators.
- Active engagement in the healthcare information services sector.
MediXall Group, Inc. Healthcare Stock: Key Questions Answered
Is MDXL a good stock?
Stock Expert AI does not rate MDXL buy, sell or hold. MediXall Group, Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What are the main risks for MDXL?
MediXall Group, Inc. faces several risks, including regulatory changes that could impact the healthcare marketplace and its operational model. The company also contends with high operational costs, which have resulted in a negative profit margin of -1474.8%.
What are the key factors to evaluate for MDXL?
Evaluate MDXL on fundamentals, analyst consensus, and risk factors. MediXall Group, Inc. is poised for growth as the demand for healthcare information services increases. Not financial advice.
How frequently does MDXL data refresh on this page?
MDXL's price was last updated on Sep 10, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven MDXL's recent stock price performance?
MediXall Group, Inc. (MDXL) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Innovative healthcare marketplace platform. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MDXL overvalued or undervalued right now?
MediXall Group, Inc. (MDXL) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of MDXL?
Yes, most major brokerages offer fractional shares of MediXall Group, Inc. (MDXL) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track MDXL's earnings and financial reports?
MediXall Group, Inc. (MDXL) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for MDXL earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial disclosures available due to OTC classification.